SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Editas Medicine, Inc. backtest

10 trend-following strategies were compared on the full daily history of Editas Medicine, Inc.. 10 beat buy-and-hold CAGR; Supertrend ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is Keltner 채널 돌파 (CAGR 1.9%, MDD -62.8%).

Data 2016-02-03 ~ 2026-07-31daily bars 2,638 (10.5 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR -17.0%, drawdown -98.9%).

Sharpe leader (same as main): Supertrend — CAGR 5.0%, MDD -88.1%, Sharpe 0.38, 49% exposure.

Return/drawdown alternative: Keltner 채널 돌파 — CAGR is 22.0%p higher than buy and hold, while drawdown improves by 10.8%p (CAGR 1.9%, MDD -62.8%, exposure 32%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
Supertrend
period=6, mult=3.5
5.0%-88.1%0.380.061.7x5049%
MACD
fast=19, slow=32, signal=18
1.2%-78.8%0.330.021.1x11253%
Keltner 채널 돌파
emaPeriod=40, atrPeriod=29, mult=1.1
1.9%-62.8%0.290.031.2x8232%
Parabolic SAR
step=0.035, maxStep=0.16
-3.3%-84.6%0.24-0.040.7x28645%
Donchian 채널 돌파
entryN=14, exitN=20
-4.6%-86.0%0.23-0.050.6x6650%
볼린저 밴드 돌파
n=50, k=0.9
-2.2%-76.9%0.22-0.030.8x6635%
ROC 모멘텀
n=38, threshold=0.06
-6.4%-90.6%0.16-0.070.5x17037%
EMA 크로스오버
fast=11, slow=99
-4.0%-84.6%0.16-0.050.6x3838%
ADX / DI 방향성
period=35, threshold=9
-8.6%-88.2%0.14-0.100.4x9843%
SMA 크로스오버
fast=55, slow=66
-6.7%-92.1%0.11-0.070.5x5243%
Buy and hold-17.0%-98.9%0.19-0.170.1x1100%
0.1 1x 10x 2017 2019 2021 2023 2025 SupertrendBuy and hold
Supertrend: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -49% -74% -99% 2017 2019 2021 2023 2025 Buy and holdSupertrend
Supertrend maximum drawdown -88.1% (2021-09-02 → 2025-05-06), prior peak not yet recovered.

Rules of the top strategy

Trades the direction of a volatility-based trend line that trails below/above price.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next